Illustrative estimate only - not verified by this sponsor. Contact the study team for actual compensation.
The goal of this randomized controlled intervention trial is to evaluate an integrated, interdisciplinary, multi-level maternity care home model (MCHM) aimed at reducing severe maternal morbidity (SMM) among a group of Black indigenous and people of color (BIPOC) patients. The main question it aims to answer is whether a patient-centered MCHM will address the gap in social, structural, and health system factors that contribute to disparities for the most vulnerable patients, thereby reducing SMM. Participants will be randomized to a MCHM (office-based prenatal care that is integrated with social services within the MCHM) or standard of care (office-based prenatal care with individually outsourced social services referrals) and followed during pregnancy through 1 year postpartum.
What happens when you apply
Reach out via phone or email to express interest
Brief call to discuss your health history
Medical screening at the research site
Begin your journey in the study
Inclusion Criteria: * Pregnant patients who self-identify as Black, Indigenous, Asian, or Latina (BIPOC) * Ages 16-55 * Presentation to the hospital in pregnancy - this includes prenatal care or the emergency department * Plan to deliver at the 2 Penn hospital sites * Patients must be able to read and understand English or Spanish * Participants must be willing and able to sign the informed consent form Exclusion Criteria: * Unable to provide written consent by being unable to read or sign informed consent. * Enrolled in ENHANCED Trial in a prior pregnancy * Already participating in Maternity Care Home Model (MCHM)
imaguineapig pulls live data from ClinicalTrials.gov (NIH/NLM).Illustrative estimate only - not verifiedPay estimates are approximate ranges based on study type and are not confirmed by sponsors — actual compensation may differ. Eligibility indicators use limited criteria (age, sex) only. We do not provide medical advice. Always contact the study team directly to confirm compensation, full eligibility, and risks before enrolling.